TELA is expected to report earnings to fall 20.41% to -40 cents per share on November 07
Q3'24
Est.
$-0.41
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.26
Q4'23
Missed
by $0.11
Q3'23
Beat
by $0.03
The last earnings report on August 12 showed earnings per share of -50 cents, missing the estimate of -46 cents. With 232.77K shares outstanding, the current market capitalization sits at 139.76M.
a commercial stage medical technology company, which focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.